Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Oxford BioMedica (OXBDF) Normalized Income after Taxes data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Normalized Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$175.28M |
|
$90.36M |
|
$133.90M |
|
$309.18M |
|
$74.65M |
|
$133.14M |
|
$144.64M |
|
$219.29M |
|
$89.89M |
|
$52.04M |
|
$89.89M |
|
105.31M |
|
| Cash Flow Statement Financials | |
$-49.47M |
|
$9.20M |
|
$12.35M |
|
$130.90M |
|
$102.75M |
|
$-28.15M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|